Citation: Rj. Dekkers et al., Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure, PERFUSION-U, 16(1), 2001, pp. 13-18
Authors:
Laithwaite, JE
Benn, SJ
Marshall, WS
FitzGerald, DJ
LaMarre, J
Citation: Je. Laithwaite et al., Divergent Pseudomonas exotoxin A sensitivity in normal and transformed liver cells is correlated with low-density lipoprotein receptor-related protein expression, TOXICON, 39(9), 2001, pp. 1283-1290
Authors:
Kreitman, RJ
Wilson, WH
Bergeron, K
Raggio, M
Stetler-Stevenson, M
FitzGerald, DJ
Pastan, I
Citation: Rj. Kreitman et al., Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia, N ENG J MED, 345(4), 2001, pp. 241-247
Authors:
Obermoeller-McCormick, LM
Li, YH
Osaka, H
FitzGerald, DJ
Schwartz, AL
Bu, GJ
Citation: Lm. Obermoeller-mccormick et al., Dissection of receptor folding and ligand-binding property with functionalminireceptors of LDL receptor-related protein, J CELL SCI, 114(5), 2001, pp. 899-908
Authors:
Daugherty, AL
McKee, ML
FitzGerald, DJ
Mrsny, RJ
Citation: Al. Daugherty et al., Epithelial application of Pseudomonas aeruginosa exotoxin A results in a selective targeting to cells in the liver, spleen and lymph node, J CONTR REL, 65(1-2), 2000, pp. 297-302
Authors:
Mrsny, RJ
Daugherty, AL
Fryling, CM
FitzGerald, DJ
Citation: Rj. Mrsny et al., Mucosal administration of a chimera composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibodyresponses, VACCINE, 17(11-12), 1999, pp. 1425-1433
Authors:
Laithwaite, JE
Benn, SJ
Yamate, J
FitzGerald, DJ
LaMarre, J
Citation: Je. Laithwaite et al., Enhanced macrophage resistance to Pseudomonas exotoxin A is correlated with decreased expression of the low-density lipoprotein receptor-related protein, INFEC IMMUN, 67(11), 1999, pp. 5827-5833